| Dr Robert G Dinwoodie, DO | |
|
30 Hill Dr, East Greenwich, RI 02818-1668 | |
| (401) 886-4405 | |
| Not Available |
| Full Name | Dr Robert G Dinwoodie |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 38 Years |
| Location | 30 Hill Dr, East Greenwich, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457358475 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 000299 (Connecticut) | Secondary |
| 207P00000X | Emergency Medicine | RI00519 (Rhode Island) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartford Healthcare Urgent Care Centers Llc | 7618242777 | 134 |
News Archive
Assistant Professor Sean Collins, Department of Microbiology and Molecular Genetics in the UC Davis College of Biological Sciences, has received a $1.5 million award from the National Institutes of Health to advance the development of "smart" immune cells for therapies to treat cancer and other diseases.
Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of a case study report based on successful treatment of Progressive Multifocal Leukoencephalopathy (PML) with combination therapy consisting of two investigational agents, Cytheris' recombinant human interleukin-7 (CYT107) and CMX001, an investigational, oral broad-spectrum antiviral drug (Chimerix, Research Triangle Park, NC) in the Journal of Antimicrobial Chemotherapy.
The malnutrition often seen in patients with Parkinson's disease could be partly an effect of levodopa medication, research suggests.
The UNDP on Thursday released a report, titled "Sex Work and the Law," which "examines 48 countries in Asia and the Pacific to assess laws, legal policies and law enforcement practices that affect the human rights of sex workers and impact on the effectiveness of HIV responses," according to a UNDP press release.
Novo Nordisk, a global healthcare company and leader in diabetes care, today announced the launch of the Novo Nordisk BlueSheet, a resource for information on diabetes and chronic disease, highlighting key issues in diabetes prevention, detection, treatment and care.
› Verified 9 days ago
| Entity Name | The William W Backus Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467517235 PECOS PAC ID: 0749170645 Enrollment ID: O20040316000739 |
News Archive
Assistant Professor Sean Collins, Department of Microbiology and Molecular Genetics in the UC Davis College of Biological Sciences, has received a $1.5 million award from the National Institutes of Health to advance the development of "smart" immune cells for therapies to treat cancer and other diseases.
Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of a case study report based on successful treatment of Progressive Multifocal Leukoencephalopathy (PML) with combination therapy consisting of two investigational agents, Cytheris' recombinant human interleukin-7 (CYT107) and CMX001, an investigational, oral broad-spectrum antiviral drug (Chimerix, Research Triangle Park, NC) in the Journal of Antimicrobial Chemotherapy.
The malnutrition often seen in patients with Parkinson's disease could be partly an effect of levodopa medication, research suggests.
The UNDP on Thursday released a report, titled "Sex Work and the Law," which "examines 48 countries in Asia and the Pacific to assess laws, legal policies and law enforcement practices that affect the human rights of sex workers and impact on the effectiveness of HIV responses," according to a UNDP press release.
Novo Nordisk, a global healthcare company and leader in diabetes care, today announced the launch of the Novo Nordisk BlueSheet, a resource for information on diabetes and chronic disease, highlighting key issues in diabetes prevention, detection, treatment and care.
› Verified 9 days ago
| Entity Name | Northeast Emergency Medicine Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982889598 PECOS PAC ID: 8729157797 Enrollment ID: O20080516000028 |
News Archive
Assistant Professor Sean Collins, Department of Microbiology and Molecular Genetics in the UC Davis College of Biological Sciences, has received a $1.5 million award from the National Institutes of Health to advance the development of "smart" immune cells for therapies to treat cancer and other diseases.
Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of a case study report based on successful treatment of Progressive Multifocal Leukoencephalopathy (PML) with combination therapy consisting of two investigational agents, Cytheris' recombinant human interleukin-7 (CYT107) and CMX001, an investigational, oral broad-spectrum antiviral drug (Chimerix, Research Triangle Park, NC) in the Journal of Antimicrobial Chemotherapy.
The malnutrition often seen in patients with Parkinson's disease could be partly an effect of levodopa medication, research suggests.
The UNDP on Thursday released a report, titled "Sex Work and the Law," which "examines 48 countries in Asia and the Pacific to assess laws, legal policies and law enforcement practices that affect the human rights of sex workers and impact on the effectiveness of HIV responses," according to a UNDP press release.
Novo Nordisk, a global healthcare company and leader in diabetes care, today announced the launch of the Novo Nordisk BlueSheet, a resource for information on diabetes and chronic disease, highlighting key issues in diabetes prevention, detection, treatment and care.
› Verified 9 days ago
| Entity Name | Hartford Healthcare Urgent Care Centers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093239683 PECOS PAC ID: 7618242777 Enrollment ID: O20170929001464 |
News Archive
Assistant Professor Sean Collins, Department of Microbiology and Molecular Genetics in the UC Davis College of Biological Sciences, has received a $1.5 million award from the National Institutes of Health to advance the development of "smart" immune cells for therapies to treat cancer and other diseases.
Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of a case study report based on successful treatment of Progressive Multifocal Leukoencephalopathy (PML) with combination therapy consisting of two investigational agents, Cytheris' recombinant human interleukin-7 (CYT107) and CMX001, an investigational, oral broad-spectrum antiviral drug (Chimerix, Research Triangle Park, NC) in the Journal of Antimicrobial Chemotherapy.
The malnutrition often seen in patients with Parkinson's disease could be partly an effect of levodopa medication, research suggests.
The UNDP on Thursday released a report, titled "Sex Work and the Law," which "examines 48 countries in Asia and the Pacific to assess laws, legal policies and law enforcement practices that affect the human rights of sex workers and impact on the effectiveness of HIV responses," according to a UNDP press release.
Novo Nordisk, a global healthcare company and leader in diabetes care, today announced the launch of the Novo Nordisk BlueSheet, a resource for information on diabetes and chronic disease, highlighting key issues in diabetes prevention, detection, treatment and care.
› Verified 9 days ago
| Entity Name | Nems Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114482882 PECOS PAC ID: 2466792833 Enrollment ID: O20190321000650 |
News Archive
Assistant Professor Sean Collins, Department of Microbiology and Molecular Genetics in the UC Davis College of Biological Sciences, has received a $1.5 million award from the National Institutes of Health to advance the development of "smart" immune cells for therapies to treat cancer and other diseases.
Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of a case study report based on successful treatment of Progressive Multifocal Leukoencephalopathy (PML) with combination therapy consisting of two investigational agents, Cytheris' recombinant human interleukin-7 (CYT107) and CMX001, an investigational, oral broad-spectrum antiviral drug (Chimerix, Research Triangle Park, NC) in the Journal of Antimicrobial Chemotherapy.
The malnutrition often seen in patients with Parkinson's disease could be partly an effect of levodopa medication, research suggests.
The UNDP on Thursday released a report, titled "Sex Work and the Law," which "examines 48 countries in Asia and the Pacific to assess laws, legal policies and law enforcement practices that affect the human rights of sex workers and impact on the effectiveness of HIV responses," according to a UNDP press release.
Novo Nordisk, a global healthcare company and leader in diabetes care, today announced the launch of the Novo Nordisk BlueSheet, a resource for information on diabetes and chronic disease, highlighting key issues in diabetes prevention, detection, treatment and care.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert G Dinwoodie, DO 30 Hill Dr, East Greenwich, RI 02818-1668 Ph: (401) 886-4405 | Dr Robert G Dinwoodie, DO 30 Hill Dr, East Greenwich, RI 02818-1668 Ph: (401) 886-4405 |
News Archive
Assistant Professor Sean Collins, Department of Microbiology and Molecular Genetics in the UC Davis College of Biological Sciences, has received a $1.5 million award from the National Institutes of Health to advance the development of "smart" immune cells for therapies to treat cancer and other diseases.
Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of a case study report based on successful treatment of Progressive Multifocal Leukoencephalopathy (PML) with combination therapy consisting of two investigational agents, Cytheris' recombinant human interleukin-7 (CYT107) and CMX001, an investigational, oral broad-spectrum antiviral drug (Chimerix, Research Triangle Park, NC) in the Journal of Antimicrobial Chemotherapy.
The malnutrition often seen in patients with Parkinson's disease could be partly an effect of levodopa medication, research suggests.
The UNDP on Thursday released a report, titled "Sex Work and the Law," which "examines 48 countries in Asia and the Pacific to assess laws, legal policies and law enforcement practices that affect the human rights of sex workers and impact on the effectiveness of HIV responses," according to a UNDP press release.
Novo Nordisk, a global healthcare company and leader in diabetes care, today announced the launch of the Novo Nordisk BlueSheet, a resource for information on diabetes and chronic disease, highlighting key issues in diabetes prevention, detection, treatment and care.
› Verified 9 days ago
Boris O Bergus, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1407 S County Trl Ste 431, East Greenwich, RI 02818 Phone: 508-769-2707 Fax: 508-480-8260 | |
Kerry Rowe, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 3461 S County Trl, East Greenwich, RI 02818 Phone: 401-471-6740 Fax: 401-471-6753 | |
Robert Gianfrocco, DO Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 3461 S County Trl, East Greenwich, RI 02818 Phone: 401-471-6740 Fax: 401-471-6753 |